EFFECT OF PHORBOL ESTER AND CYTOKINES ON MATRIX METALLOPROTEINASE AND TISSUE INHIBITOR OF METALLOPROTEINASE EXPRESSION IN TUMOR AND NORMAL-CELL LINES

被引:0
|
作者
MACKAY, AR [1 ]
BALLIN, M [1 ]
PELINA, MD [1 ]
FARINA, AR [1 ]
NASON, AM [1 ]
HARTZLER, JL [1 ]
THORGEIRSSON, UP [1 ]
机构
[1] SPERIMENTALE COLLEMAGGIO,DIPARTIMENTO MED,LAQUILA,ITALY
来源
INVASION & METASTASIS | 1992年 / 12卷 / 3-4期
关键词
12-O-TETRADECANOYLPHORBOL-13-ACETATE; INTERLEUKIN-1; TUMOR NECROSIS FACTOR-ALPHA; MATRIX METALLOPROTEINASES; METALLOPROTEINASE INHIBITORS; AP-1-BINDING PROTEIN;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effect of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) and the cytokines interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha) on matrix metalloproteinases (MMP) and metalloproteinase inhibitors was studied in a variety of human cell lines. Expression of the mammalian collagenase (MMP-1), 72-kD gelatinase/type IV collagenase (MMP-2), stromelysin (MMP-3), 92-kD getatinase/type IV collagenase (MMP-9), and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) was assessed by zymography and Northern blot analysis. MMP-2 and TIMP-2 activities were refractory to TPA, IL-1 and TNF-alpha treatment in most of the cell lines. In contrast, MMP-3, MMP-9 and TIMP-1 activities were markedly stimulated by TPA in most of the tumor cell lines and human umbilical vein endothelial cells (HUVEC), whereas the fibroblast lines were minimally stimulated or unresponsive to TPA. The MMP-3, MMP-9 and TIMP-1 stimulation in response to IL-1 and TNF-alpha treatment was detected in some of the tumor cell lines and HUVEC. The increase in activity was less marked than in TPA. A breast carcinoma cell line, MDA-MB-231, which did not express MMP-2, had high expression of MMP-3 and MMP-9 which were unaffected bv TPA and cytokine treatment. Northern blot analysis of MMP and TIMP mRNA expression reflected the zymogram findings for most of the cell lines. TPA-mediated stimulation of MMP-1 was similar to that of MMP-3 and MMP-9. Exceptions were the fibroblast cell lines which showed either a much more marked mRNA response of MMP-9 to TPA than observed at protein level, or a high constitutive MMP-9 mRNA when MMP-9 activity was not detectable by zymography. TPA-mediated stimulation of MMP-9 and TIMP-1 activity was blocked by staurosporine, an inhibitor of protein kinase C (PKC). A non-PKC-activating phorbol ester, 4alpha-phorbol-12,13-didecanoate, did not stimulate MMP-9 and TIMP-1 activity. TPA treatment caused the increased expression of c-fos containing AP-1-specific binding activity in selected tumor cell lines. This activity was maximal at 6 h. An association was observed between AP-1 binding activity and increased expression of MMP-1, MMP-3 and MMP-9. which possess TPA-responsive elements (TRE). TPA-sensitive MMPs and TIMP-1 were variably stimulated by biologically relevant cytokines, such as IL-1 and TNF-alpha. TNF-alpha mediated an increase in MMP-9, but not TIMP-1 activity, in a lung carcinoma cell line (A-549). This suggests that cytokines may cause an imbalance in metalloproteinase and TIMP secretion by tumor cells in certain cases, which would favor extracellular matrix degradation. These data from a variety of normal and human tumor cell lines suggest that MMP-2 and TIMP-2 are regulated differently from MMP-1, MMP-3, MMP-9 and TIMP-1 by activators of PKC.
引用
收藏
页码:168 / 184
页数:17
相关论文
共 50 条
  • [21] Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer
    Ross, JS
    Kaur, P
    Sheehan, CE
    Fisher, HAG
    Kaufman, RA
    Kallakury, BVS
    MODERN PATHOLOGY, 2003, 16 (03) : 198 - 205
  • [23] Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate
    Hashimoto, K
    Kihira, Y
    Matuo, Y
    Usui, T
    JOURNAL OF UROLOGY, 1998, 160 (05): : 1872 - 1876
  • [24] Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13 tissue inhibitor of metalloproteinase 1 expression in murine silicosis
    Ortiz, LA
    Lasky, J
    Gozal, E
    Ruiz, V
    Lungarella, G
    Cavarra, E
    Brody, AR
    Friedman, M
    Pardo, A
    Selman, M
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (01) : 244 - 252
  • [25] Co-expression of matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinase 2 in prostatic adenocarcinomas (PACs).
    Ross, JS
    Kaur, P
    Smith, K
    Sheehan, CE
    Fisher, HAG
    Kaufman, RP
    Kallakury, BVS
    MODERN PATHOLOGY, 2001, 14 (01) : 121A - 121A
  • [26] Co-expression of matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinase 2 in prostatic adenocarcinomas (PACs).
    Ross, JS
    Kaur, P
    Smith, K
    Sheehan, CE
    Fisher, HAG
    Kaufman, RP
    Kallakury, BVS
    LABORATORY INVESTIGATION, 2001, 81 (01) : 121A - 121A
  • [27] Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma
    Gao, ZB
    Duan, YQ
    Zhang, L
    Chen, DW
    Ding, PT
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2005, 16 (04) : 599 - 603
  • [28] Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium
    Chung, HW
    Lee, JY
    Moon, HS
    Hur, SE
    Park, MH
    Wen, Y
    Polan, ML
    FERTILITY AND STERILITY, 2002, 78 (04) : 787 - 795
  • [29] Effect of Latanoprost on the Expression of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinase 1 on the Ocular Surface
    Honda, Norihiko
    Miyai, Takashi
    Nejima, Ryohei
    Miyata, Kazunori
    Mimura, Tatsuya
    Usui, Tomohiko
    Aihara, Makoto
    Araie, Makoto
    Amano, Shiro
    ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (04) : 466 - 471
  • [30] Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3
    Zhang, J
    Cao, YJ
    Zhao, YG
    Sang, QXA
    Duan, EK
    MOLECULAR HUMAN REPRODUCTION, 2002, 8 (07) : 659 - 666